Evidence map›Paper›PMID 35049653›Full record

ArticleBiosensors2022

Substituent Effects Impact Surface Charge and Aggregation of Thiophenol-Labeled Gold Nanoparticles for SERS Biosensors.

Nolan File, Joseph Carmicheal, Alexey V Krasnoslobodtsev, Nicole C Japp, Joshua J Souchek, Sudesna Chakravarty, Michael A Hollingsworth, Aaron A Sasson, Gopalakrishnan Natarajan, Prakash G Kshirsagar and 5 more

Abstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nolan FileSanguine Diagnostics and Therapeutics Inc., Omaha, NE 68106, USA.ORCID 0000-0001-9940-2410
Joseph CarmichealDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-9669-8241
Alexey V KrasnoslobodtsevDepartment of Physics, University of Nebraska at Omaha, Omaha, NE 68182, USA.ORCID 0000-0001-9233-0936
Nicole C JappSanguine Diagnostics and Therapeutics Inc., Omaha, NE 68106, USA.ORCID 0000-0002-6672-5640
Joshua J SouchekSanguine Diagnostics and Therapeutics Inc., Omaha, NE 68106, USA.ORCID 0000-0002-7607-2823
Sudesna ChakravartyDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Michael A HollingsworthSanguine Diagnostics and Therapeutics Inc., Omaha, NE 68106, USA.
Aaron A SassonSanguine Diagnostics and Therapeutics Inc., Omaha, NE 68106, USA.
Gopalakrishnan NatarajanDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Prakash G KshirsagarDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Maneesh JainDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Chihiro HayashiDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Wade M JunkerSanguine Diagnostics and Therapeutics Inc., Omaha, NE 68106, USA.
Sukhwinder KaurDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Surinder K BatraSanguine Diagnostics and Therapeutics Inc., Omaha, NE 68106, USA.ORCID 0000-0001-9470-9317

Funding

Pancreatic Cancer Detection ConsortiumU01CA210240 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Michael A. Hollingsworth · 2017 to 2026
$12.9M
Validation of biomarkers for risk prediction and early diagnosis of Pancreatic AdenocarcinomaU01CA200466 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Surinder K. Batra, Randall Brand · 2016 to 2026
$11.3M
Ultrasensitive SERS Nano-Sensors for Pancreatic Cancer Diagnosis and PrognosisR41CA213718 · NCI · SANGUINE DIAGNOSTICS AND THERAPEUTICS · PI JUNKER, WADE M, KAUR, SUKHWINDER · 2016 to 2016
$300k
NCI NIH HHS R41 CA213718NCI NIH HHS R41CA213718NCI NIH HHS U01CA200466NCI NIH HHS U01 CA210240NCI NIH HHS U01CA210240
6 · The paper itself

Abstract

SERS immunoassay biosensors hold immense potential for clinical diagnostics due to their high sensitivity and growing interest in multi-marker panels. However, their development has been hindered by difficulties in designing compatible extrinsic Raman labels. Prior studies have largely focused on spectroscopic characteristics in selecting Raman reporter molecules (RRMs) for multiplexing since the presence of well-differentiated spectra is essential for simultaneous detection. However, these candidates often induce aggregation of the gold nanoparticles used as SERS nanotags despite their similarity to other effective RRMs. Thus, an improved understanding of factors affecting the aggregation of RRM-coated gold nanoparticles is needed. Substituent electronic effects on particle stability were investigated using various para-substituted thiophenols. The inductive and resonant effects of functional group modifications were strongly correlated with nanoparticle surface charge and hence their stability. Treatment with thiophenols diminished the negative surface charge of citrate-stabilized gold nanoparticles, but electron-withdrawing substituents limited the magnitude of this diminishment. It is proposed that this phenomenon arises by affecting the interplay of competing sulfur binding modes. This has wide-reaching implications for the design of biosensors using thiol-modified gold surfaces. A proof-of-concept multiplexed SERS biosensor was designed according to these findings using the two thiophenol compounds with the most electron-withdrawing substitutions: NO

Indexed as

Biosensing TechniquesMetal NanoparticlesGoldPhenolsSpectrum Analysis, RamanSulfhydryl CompoundsGoldPhenolsSulfhydryl CompoundsthiophenolaggregationimmunoassaymultiplexingnanoparticlesRaman reporter moleculesSERS

Identifiers

PMID35049653
PMCPMC8773556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.